Latest News

Newly identified antibodies effectively treat Alzheimer's-like disease in mice

Alzheimer's disease is characterized by the accumulation of particular toxic proteins in the brain that are believed to underlie the cognitive decline in patients. A new study conducted in mice suggests that newly identified antibody treatments can prevent the accumulation of one of these of these toxic components, called tau proteins. The findings suggest that these antibodies may provide a basis for a promising therapy for patients with Alzheimer's disease and other neurodegenerative disorders.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Multiple sclerosis: Review of current treatments for physicians

  • Researchers compare hip width and sexual behavior

  • Some astronauts at risk for cognitive impairment, animal studies suggest

  • Hearing quality restored with bionic ear technology used for gene therapy: Re-growing auditory nerves

  • Finding safe drugs to treat neurodegenerative diseases

  • Loss of memory in Alzheimer's mice models reversed through gene therapy

  • Novel compound halts cocaine addiction, relapse behaviors

  • Safer alternatives to nonsteroidal antinflamatory pain killers

  • Mystery behind general anesthetic action becoming more clear

  • Narrowing of neck artery without warning may signal memory, thinking decline

  •